Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
February 11, 2020
Lead Product(s) : Doxorubicin Hydrochloride,Bleomycin Sulphate,Vinblastine Sulfate,PET,Dacarbazine,Etoposide,Cyclophosphamide,Vincristine Sulfate,Procarbazine Hydrochloride,Prednisone
Therapeutic Area : Oncology
Study Phase : Phase II
Sponsor : National Cancer Institute
Deal Size : Inapplicable
Deal Type : Inapplicable
Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma
Details : Undisclosed
Product Name : Undisclosed
Product Type : Cytotoxic Drug
Upfront Cash : Inapplicable
July 11, 2011
Lead Product(s) : Doxorubicin Hydrochloride,Bleomycin Sulphate,Vinblastine Sulfate,PET,Dacarbazine,Etoposide,Cyclophosphamide,Vincristine Sulfate,Procarbazine Hydrochloride,Prednisone
Therapeutic Area : Oncology
Highest Development Status : Phase II
Sponsor : National Cancer Institute
Deal Size : Inapplicable
Deal Type : Inapplicable